文献速递乳腺乳腺X线

筛查乳腺X线摄影测试集判读表现与临床实践表现的相关性

Correlation Between Screening Mammography Interpretive Performance on a Test Set and Performance in Clinical Practice.
PubMed 文献 · Acad Radiol · 2017-05-24

该研究将83名放射科医生随机分配至四个测试集之一(各109例筛查乳腺X线摄影),48名医生2年后完成第五个测试集(110例)。测试集在癌症例数和病灶检测难度上不同。测试集敏感度和特异度与临床实践表现之间的Spearman秩相关系数为弱至中度,癌症例数较多的测试集相关性接近0且无统计学显著性。

要点

  • 测试集判读表现与临床实践表现的相关性并不强。
  • 癌症患病率低且病灶检测困难的测试集,其敏感度相关性为弱至中度。
  • 癌症例数较多的测试集,敏感度与特异度相关性接近0且无统计学显著性。

核心结论

  • 测试集筛查表现与临床实践表现之间的相关性不强;当测试集中癌症患病率低且病灶检测困难时,测试集表现更能准确反映临床实践表现。

研究设计与样本

  • 经机构审查委员会批准的研究,将来自六个乳腺癌监测联盟登记处的83名放射科医生随机分配至四个测试集之一,每个测试集含109例筛查乳腺X线摄影;48名医生在2年后完成第五个测试集(110例乳腺X线摄影)。测试集在癌症例数和病灶检测难度上不同。测试集敏感度和特异度以癌症状态和专家意见作为金标准,采用女性水平和乳腺水平召回进行估计;临床实践表现以癌症状态作为金标准,采用女性水平召回进行估计。

诊断标准与关键数值

  • 癌症例数较少(N=15)且检测更困难的测试集:敏感度女性水平相关系数=0.46(95%CI=0.16, 0.69),乳腺水平相关系数=0.35(95%CI=0.03, 0.61);特异度相关系数=0.24(95%CI=0.01, 0.45),均相对于专家召回。
  • 癌症例数较多(N=30)的测试集:敏感度与特异度相关系数接近0且无统计学显著性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Evidence is inconsistent about whether radiologists' interpretive performance on a screening mammography test set reflects their performance in clinical practice. This study aimed to estimate the correlation between test set and clinical performance and determine if the correlation is influenced by cancer prevalence or lesion difficulty in the test set.

MATERIALS AND METHODS: This institutional review board-approved study randomized 83 radiologists from six Breast Cancer Surveillance Consortium registries to assess one of four test sets of 109 screening mammograms each; 48 radiologists completed a fifth test set of 110 mammograms 2 years later. Test sets differed in number of cancer cases and difficulty of lesion detection. Test set sensitivity and specificity were estimated using woman-level and breast-level recall with cancer status and expert opinion as gold standards. Clinical performance was estimated using women-level recall with cancer status as the gold standard. Spearman rank correlations between test set and clinical performance with 95% confidence intervals (CI) were estimated.

RESULTS: For test sets with fewer cancers (N = 15) that were more difficult to detect, correlations were weak to moderate for sensitivity (woman level = 0.46, 95% CI = 0.16, 0.69; breast level = 0.35, 95% CI = 0.03, 0.61) and weak for specificity (0.24, 95% CI = 0.01, 0.45) relative to expert recall. Correlations for test sets with more cancers (N = 30) were close to 0 and not statistically significant.

CONCLUSIONS: Correlations between screening performance on a test set and performance in clinical practice are not strong. Test set performance more accurately reflects performance in clinical practice if cancer prevalence is low and lesions are challenging to detect.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Miglioretti DL, Ichikawa L, Smith RA, et al. Correlation Between Screening Mammography Interpretive Performance on a Test Set and Performance in Clinical Practice. Acad Radiol. 2017. PMID: 28551400. doi:10.1016/j.acra.2017.03.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。